Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis
Abstract Tissue repair is disturbed in fibrotic diseases like systemic sclerosis (SSc), where the deposition of large amounts of extracellular matrix components such as collagen interferes with organ function. LAIR-1 is an inhibitory collagen receptor highly expressed on tissue immune cells. We questioned whether in SSc, impaired LAIR-1-collagen interaction is contributing to the ongoing inflammation and fibrosis.We found that SSc patients do not have an intrinsic defect in LAIR-1 expression or function. Instead, fibroblasts from SSc patients deposit disorganized collagen productsin vitro, which are dysfunctional LAIR-1 ligands. This can be mimicked in healthy fibroblasts stimulated by soluble factors that drive inflammation and fibrosis in SSc and is dependent of matrix metalloproteinases and platelet-derived growth factor receptor signaling.In support of a non-redundant role of LAIR-1 in the control of fibrosis, we found that LAIR-1-deficient mice have increased skin fibrosis in response to repeated injury and in the bleomycin mouse model for SSc. Thus, LAIR-1 represents an essential control mechanism for tissue repair. In fibrotic disease, excessive collagen degradation may lead to a disturbed feedback loop. The presence of functional LAIR-1 in patients provides a therapeutic opportunity to reactivate this intrinsic negative feedback mechanism in fibrotic diseases..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 09. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Carvalheiro, Tiago [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2021.12.07.471103 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI033177228 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI033177228 | ||
| 003 | DE-627 | ||
| 005 | 20231205150247.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211209s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.12.07.471103 |2 doi | |
| 035 | |a (DE-627)XBI033177228 | ||
| 035 | |a (biorXiv)10.1101/2021.12.07.471103 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Carvalheiro, Tiago |e verfasserin |0 (orcid)0000-0002-3187-2288 |4 aut | |
| 245 | 1 | 0 | |a Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Tissue repair is disturbed in fibrotic diseases like systemic sclerosis (SSc), where the deposition of large amounts of extracellular matrix components such as collagen interferes with organ function. LAIR-1 is an inhibitory collagen receptor highly expressed on tissue immune cells. We questioned whether in SSc, impaired LAIR-1-collagen interaction is contributing to the ongoing inflammation and fibrosis.We found that SSc patients do not have an intrinsic defect in LAIR-1 expression or function. Instead, fibroblasts from SSc patients deposit disorganized collagen productsin vitro, which are dysfunctional LAIR-1 ligands. This can be mimicked in healthy fibroblasts stimulated by soluble factors that drive inflammation and fibrosis in SSc and is dependent of matrix metalloproteinases and platelet-derived growth factor receptor signaling.In support of a non-redundant role of LAIR-1 in the control of fibrosis, we found that LAIR-1-deficient mice have increased skin fibrosis in response to repeated injury and in the bleomycin mouse model for SSc. Thus, LAIR-1 represents an essential control mechanism for tissue repair. In fibrotic disease, excessive collagen degradation may lead to a disturbed feedback loop. The presence of functional LAIR-1 in patients provides a therapeutic opportunity to reactivate this intrinsic negative feedback mechanism in fibrotic diseases. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Marut, Wioleta |4 aut | |
| 700 | 1 | |a Pascoal Ramos, M. Inês |0 (orcid)0000-0003-3644-6517 |4 aut | |
| 700 | 1 | |a García, Samuel |4 aut | |
| 700 | 1 | |a Fleury, Devan |4 aut | |
| 700 | 1 | |a Affandi, Alsya J. |4 aut | |
| 700 | 1 | |a Meijers, Aniek S. |4 aut | |
| 700 | 1 | |a Giovannone, Barbara |4 aut | |
| 700 | 1 | |a Tieland, Ralph G. |4 aut | |
| 700 | 1 | |a Elshof, Eline |4 aut | |
| 700 | 1 | |a Ottria, Andrea |4 aut | |
| 700 | 1 | |a Cossu, Marta |4 aut | |
| 700 | 1 | |a Meizlish, Matthew L. |4 aut | |
| 700 | 1 | |a Veenendaal, Tineke |4 aut | |
| 700 | 1 | |a Ramanujam, Meera |4 aut | |
| 700 | 1 | |a Moreno-García, Miguel E. |4 aut | |
| 700 | 1 | |a Klumperman, Judith |4 aut | |
| 700 | 1 | |a Liv, Nalan |0 (orcid)0000-0003-2654-9117 |4 aut | |
| 700 | 1 | |a Radstake, Timothy R.D.J. |4 aut | |
| 700 | 1 | |a Meyaard, Linde |0 (orcid)0000-0003-0707-4793 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 09. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:09 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.12.07.471103 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 09 |c 10 | ||